Free Cash Flow Build Up

TRxADE HEALTH, Inc. (MEDS)

$ 4.57
-0.44 (-8.78%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 0.961.502.912.482.933.837.4417.1227.1443.0268.19108.09171.32
EBITDA -2.08-1.43-0.13-2.610.450.07-0.05-1.68-14.12-22.38-35.47-56.22-89.12
EBIT -2.08-1.43-0.14-2.620.440.06-0.07-1.73-14.20-22.50-35.67-56.54-89.61
Tax Rate 0.00%0.00%-335.41%-135.28%0.00%0.00%0.00%0.00%-58.84%-58.84%-58.84%-58.84%-58.84%
EBIAT -2.08-1.43-0.60-6.150.440.06-0.07-1.73-22.55-35.74-56.65-89.80-142.34
Depreciation 0000.010.010.010.020.050.080.120.200.310.50
Accounts Receivable --0.08-0.010.06-0.02-0.11-0.36-1.10-2.15-2.37-3.75-5.95-9.43
Inventories --0-0.060.02-0.02-0.03-0.14-0.37-0.38-0.61-0.96-1.52-2.42
Accounts Payable -0.13-0.070.02-0.130.29-0.07-0.082.241.462.323.675.82
Capital Expenditure -0.01-0.02-0.03-0.03-0.03-0.02-0.08-0.04-0.31-0.49-0.78-1.24-1.97
UFCF -2.09-1.40-0.77-6.090.240.17-0.70-3.42-23.08-37.62-59.64-94.53-149.84
WACC
PV UFCF -18.45-26.89-38.10-54-76.53
SUM PV UFCF -239.32